20918 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Methods for modulating immune responses
#3002Immunotherapy against several tumors including gastrointestinal and gastric cancer
#3003Modulating the alternative complement pathway
#3004NOVEL SURFACE MARKERS FOR ADIPOSE TISSUE
#3005METHOD OF TREATING AND PREVENTING OCULAR ANGIOGENESIS
#3006COMPOSITION FOR INCREASING MUSCLE MASS AND A PROCESS FOR PRODUCING THE SAME
#3007Apolipoprotein A-I mimics
#3008Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils
#3009Lipid formulations for delivery of messenger RNA
#3010Compositions and methods for promoting wound healing and tissue regeneration
#3011Methods and compositions for modulating toso activity
#3012Compositions which regulate the epithelial brush border Na/H exchanger NHE3 and their methods of use in gastrointestinal disease
#3013Methods and compositions for inhibiting diseases of the central nervous system
#3014Methods of treatment of cancer using SRC-modulating peptides
#3015RADIATION STERILIZATION-RESISTANT PROTEIN COMPOSITION
#3016Mutant adeno-associated virus virions and methods of use thereof
#3017Combination Treatment of Multiple Myeloma
#3018Fused ring compound for use as mineralocorticoid receptor antagonist
#3019Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of diabetes
#3020Compositions and methods for lung regeneration
#3021Production of TSG-6 Protein
#3022Use of Histones for Therapeutic Purposes
#3023Administration of angiocidin for arresting the growth of a tumor cell
#3024Methods and compositions for the treatment of cancer and infectious disease using alpha(2) macroglobulin-antigenic molecule complexes
#3025Pharmaceutical use of FAM19A5 involved in regulating gliogenesis
#3026Modified peptides and their use for treating autoimmune diseases
#3027Methods and compositions for activation of sirtuins with Annexin A1 peptides
#3028WNT7A compositions and method of using the same
#3029CNS DELIVERY OF MRNA AND USES THEREOF
#3030Methods of preventing rejection of transplanted tissue by administering anti-CD40L antibody and dendritic cells loaded with type B peptide
#3031hDC-sign binding peptides
#3032COMPOSITIONS COMPRISING MG53 AND METHODS FOR THE TREATMENT AND PREVENTION OF AIRWAY INJURY
#3033Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein
#3034Non-N-glycosylated recombinant human annexin A2
#3035Medical food for high cortisol breast cancer
#3036Cytokines and neuroantigens for treatment of immune disorders
#3037C1q/TNF-RELATED PROTEIN-9 (CTRP9) AND USE IN PREVENTION AND TREATMENT OF METABOLIC DISORDERS
#3038Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
#3039USE OF NUTRITIONAL COMPOSITIONS FOR PREVENTING DISORDERS
#3040Use of the cathelicidin LL-37 and derivatives thereof for wound healing
#3041BIOACTIVE COMPLEX COMPOSITIONS AND METHODS OF USE THEREOF
#3042Peptides for management of lactation
#3043Use of immunesuppressant receptor
#3044Vault and vault like carrier molecules
#3045Sugar compositions for treating hemophilia A and/or von Willebrand disease
#3046Genes and proteins associated with angiogenesis and uses thereof
#3047METHODS FOR TREATING HEAT STRESS AND RELATED COMPOSITIONS
#3048Spalt-like transcription factor 4 (SALL4) and uses thereof
#3049PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS
#3050REGENERATION OF INNER EAR CELLS
#3051Alpha B-Crystallin as a Therapy for Ischemia or Inflammation
#3052METHOD FOR HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT
#3053METHOD FOR THE HARVESTING, PROCESSING, AND STORAGE OF PROTEINS FROM THE MAMMALIAN FETO-PLACENTAL UNIT AND USE OF SUCH PROTEINS IN COMPOSITIONS AND MEDICAL TREATMENT
#3054TFEB GENE THERAPY OF ALPHA-1-ANTITRYPSIN DEFICIENCY
#3055Recombinant AAV capsid protein
#3056Treatment of drug resistant cancer
#3057Methods and compositions to regulate hepcidin expression
#3058Methods for weight loss and ketogenic compositions
#3059RNASE 7 ANTIMICROBIAL PEPTIDES
#3060FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
#3061Sterically Stabilized Carrier For Aerosol Therapeutics, Compositions And Methods For Treating The Respiratory Tract Of A Mammal
#3062Method for blocking tumour growth
#3063Cyclic peptide inhibitors of lysine-specific demethylase 1
#3064NANOSTRUCTURES FOR TREATING CANCERS AND OTHER CONDITIONS
#3065Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
#3066Use of engrailed proteins for increasing dopamine synthesis by dopaminergic neurons
#3067Method of treating bone disorders using TSG-6
#3068PRODRUG COMPRISING A DRUG LINKER CONJUGATE
#3069Bone morphogenic protein binding peptide
#3070FOOD SUPPLEMENT TO SUPPORT BRAIN FUNCTION
#3071MODIFICATION OF FEEDING BEHAVIOR
#3072Peptide and uses therefor
#3073Enhancement of osteogenic potential of bone grafts
#3074Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease
#3075Method for treating diabetic retinopathy
#3076Dry powder inhaler and system for drug delivery
#3077Methods and composition for inducing satiety
#3078NANOPARTICLE AGGREGATES CONTAINING OSTEOPONTIN AND CALCIUM- AND/OR STRONTIUM-CONTAINING PARTICLES
#3079METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATIVE DISEASES
#3080Simukunin
#3081Histamine-releasing factor (HRF), HRF-receptor and methods of modulating inflammation
#3082ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2
#3083Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1
#3084ADAM22 for use as a prognostic variable, and target for therapy, of a metastatic breast cancer disease
#3085Use of stem cells to generate inner ear cells
#3086Composition and method for the treatment or prevention of spinal disorders
#3087Method for inhibiting euPTX3 to treat nasopharyngeal carcinoma by amino acid sequence
#3088Treatment of amyloidoses using myelin basic protein and fragments thereof
#3089Protection against and treatment of ionizing radiation
#3090Modulation of activity of proneurotrophins
#3091ActRIIB proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
#3092Treatment and diagnosis of melanoma
#3093COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#3094Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
#3095Phosphorylation on the Thr-248 and/or Thr-250 residues of transcription factor E2F4 as a therapeutic target in pathological processes associated with somatic polyploidy
#3096Endomucin as an anti-inflammatory agent
#3097Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
#3098Methods for treating cardiac conditions
#3099EMT-INDUCING TRANSCRIPTION FACTORS COOPERATE WITH SOX9
#3100Nutritive fragments, proteins and methods
#3101REGENERATION OF ISLET BETA CELLS BY HSP60 DERIVED PEPTIDES
#3102Method of treating diabetes using non-glycosylated apolipoprotein A-IV
#3103USES OF CASEIN COMPOSITIONS
#3104Method of identifying a compound for treating a hypoxic or ischemic related disorder
#3105Compounds and methods for the treatment of vascular disease
#3106THERAPEUTIC METHOD OF TREATMENT FOR INHIBITING TUMOR DEVELOPMENT USING TAMM-HORSFALL GLYCOPROTEIN (THP) AS IMMUNOSTIMULATING DRUG AND COMPOSITIONS
#3107METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDS
#3108Methods of reducing the effects of exposure to a mustard compound by administering RLIP76
#3109METHODS FOR TREATING ERECTILE DYSFUNCTION IN PATIENTS WITH INSULIN-DEPENDENT DIABETES
#3110Composition for controlled release of physiologically active substance
#3111TUSC2 therapies
#3112METHODS FOR INHIBITING HIV-1 REPLICATION INVOLVING THE ADMINISTRATION OF AN ANTI-CCR5 RECEPTOR MONOCLONAL ANTIBODY AND SMALL MOLECULE CCR5 RECEPTOR ANTAGONIST
#3113Alpha-1 antitrypsin variant, preparation method thereof and use thereof
#3114Use of liposomal WNT composition to enhance osseointegration
#3115Myonectin (CTRP15), compositions comprising same, and methods of use
#3116Modified epitopes for boosting CD4+ T-cell responses
#3117Method and composition for inducing human pluripotent stem cells
#3118Glypican-4 based compositions and methods for treating and diagnosing insulin resistance
#3119Oxidized cardiolipin as a pro-inflammatory factor
#3120Method of reducing cell death by administering a nucleic acid encoding a paracrine factor of a mesenchymal stem cell
#3121Therapeutic approach for polyglutamine degeneration
#3122METHODS FOR ENHANCEMENT OF MUSCLE PROTEIN SYNTHESIS
#3123NUTRITIONAL COMPOSITION FOR WOUND HEALING
#3124Methods for preventing or treating certain disorders by inhibiting binding of IL-4 and/or IL-13 to their respective receptors
#3125Neutralizing antibodies and methods of use thereof
#3126PROTOCOLS FOR TREATING AND PREVENTING OBESITY AND COMPLICATIONS ARISING THEREFROM
#3127COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS
#3128Method for treating brain cancer using a novel tumor suppressor gene and secreted factor
#3129Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment
#3130TARGETING EN2, PAX2, AND/OR DEFB1 FOR TREATMENT OF PROSTATE CONDITIONS
#3131Removal of serine proteases by treatment with finely divided silicon dioxide
#3132Factor H for treatment of rheumatoid arthritis
#3133Therapeutic use of activators of zinc finger protein GL13
#3134ACTH prophylactic treatment of renal disorders
#3135Methods and compositions for enhancing the uptake of therapeutic agents by target cells
#3136Factor H for transplantation
#3137UTILITY OF INSULIN-LIKE 6 (INSL6) FOR THE TREATMENT OF AUTOIMMUNE DISEASES
#3138Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
#3139Use Of Complement Inhibitors To Treat Ocular Diseases
#3140Human skin equivalents expressing exogenous polypeptides
#3141Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
#3142Peptide YY analogs
#3143METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#3144Use of HDL-related molecules to treat and prevent proinflammatory conditions
#3145Use of fibromodulin and lumican for increasing muscle mass
#3146Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
#3147Methods of using ZSCAN4 for rejuvenating human cells
#3148Use of Ferritin to Treat Iron Disorders
#3149Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
#3150Synthetic pentasaccharides having short half-life and high activity
#3151Use of an Active Biological Substance in Abnormal Cellular and Viral Membrane Physiologies
#3152Veterinary decorin compositions and use thereof
#3153Isolated nucleotide sequences encoding GDF traps
#3154Immunogenic tumor associated stromal cell antigen peptides and methods of their use
#3155PEPTIDE-MEDIATED DELIVERY OF ACTIVE AGENTS ACROSS THE BLOOD-BRAIN BARRIER
#3156Rhinosinusitis Prevention and Therapy with Proinflammatory Cytokine Inhibitors
#3157Compositions and methods for the induction and tuning of gene expression
#3158COMBINATION OF ACTIVE INGREDIENTS FOR THE TREATMENT OF ACUTE KIDNEY INJURY
#3159Compositions of active Wnt protein
#3160Dietary product intended to reduce visceral fat during the pre-operative phase prior to bariatric surgery
#3161Methods for treating kidney disease with fragments of ApoB-100
#3162Combination immunotherapy for the treatment of cancer
#3163Extracellular histones as biomarkers for prognosis and molecular targets for therapy
#3164METHODS FOR DIAGNOSING AND TREATING MYHRE SYNDROME
#3165Mitochondrial proteins constructs and uses thereof
#3166METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS
#3167Therapeutic agent for infections, and treatment method using same
#3168Targeting GLI proteins in human cancer by small molecules
#3169Treating cartilage defect with UCB-MSC expressing TSP-2
#3170Endothelium protective materials and methods of use
#3171Apoptosis-targeting nanoparticles
#3172Delaying the progression of diabetes
#3173METHOD OF TREATING MUCUS HYPERSECRETION
#3174Cysteine Peptide-Containing Health Drink
#3175COMPOSITIONS AND METHODS FOR DENTAL TISSUE REGENERATION
#3176Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
#3177Method for therapeutic replenishment and enrichment of ocular surface lubrication
#3178METHOD OF PREVENTING DEVELOPMENT OF PSORIATIC LESIONS
#3179Method of reducing cell death by administering a paracrine factor derived from a mesenchymal stem cell
#3180Compositions and methods for the treatment of cardiac surgery-associated acute kidney injury with annexin A1 peptide
#3181MEDICAMENT FOR THE TREATMENT OF FUNGAL INFECTIONS PARTICULARLY ASPERGILLOSIS
#3182METHODS FOR DIAGNOSING AND TREATING ALZHEIMER'S DISEASE BY ADMINISTERING AN ANTI-ANGIOGENIC AGENT
#3183Intranasal administration of agents with pro-inflammatory activity for the therapy of neurological disorders
#3184Inhibition of c-Myc ubiquitination to prevent cancer initiation and progression
#3185Methods, compositions and screens for therapeutics for the treatment of synovial sarcoma
#3186Dietary product intended for the prevention of cardiometabolic risk
#3187Lipid therapy
#3188Giant obscurins and uses thereof in cancer prognosis and therapy
#3189Treatment of heart disease by inhibition of the action of ribosomal S6 kinase 3 (RSK3)
#3190Protein therapy for treatment of retinal diseases
#3191PSMA antibodies and uses thereof
#3192Methods of Use for Recombinant Human Secretoglobins
#3193METHOD OF GENERATING AN INDEX SCORE FOR MBL DEFICIENCY TO PREDICT CARDIODIABETES RISK
#3194Epigenetic biomarker ZNF545 for diagnosing and prognosis of gastric cancer
#3195Vectors encoding a paralytic peptide
#3196Reducing proinflammatory response
#3197Nutritional compositions containing a peptide component and uses thereof
#3198Co-activation of mTOR and STAT3 pathways to promote neuronal survival and regeneration
#3199WHEY PROTEIN MICELLES TO ENHANCE MUSCLE MASS AND PERFORMANCE
#3200Compositions and Methods for Delivery of High-Affinity Oxygen Binding Agents to Tumors
#3201SRPX for treatment of cancer
#3202Methods of treating cognitive impairment
#3203Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
#3204USE OF HEMOPEXIN TO SEQUESTER HEMOGLOBIN
#3205Nanoparticle peptide compositions
#3206WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA
#3207Compound and method for treatment of Alzheimer's disease
#3208Cell secreted proteins for the treatment of myocardial infarction
#3209Antibodies which bind to signal peptide-containing molecules
#3210DISEASE TREATMENT VIA ANTIMICROBIAL PEPTIDES OR THEIR INHIBITORS
#3211Methods for generating cardiomyocytes
#3212INSULIN INDEPENDENCE AMONG PATIENTS WITH DIABETES UTILIZING A PPI IN COMBINATION WITH AN IMMUNE TOLERANCE AGENT
#3213SUMOYLATION OF SERCA2a AND CARDIOVASCULAR DISEASE
#3214PROPHYLACTIC AND THERAPEUTIC AGENT FOR NEUROLOGICAL DISEASES USING LIPOPROTEINS AND PROPHYLACTIC AND THERAPEUTIC METHOD FOR NEUROLOGICAL DISEASES
#3215Annexin A2 and tissue plasminogen activator for treating vascular disease
#3216Protein complex comprising MCM8 and MCM9 proteins and their use
#3217Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
#3218Methods and compositions for delivery of exogenous factors to nervous system sites
#3219Nanoparticle delivery compositions
#3220Diagnosis and treatment of prostate cancer
#3221STIP1 polypeptides and uses thereof
#3222RRECOMBINANT HUMAN SAPOSIN B PROTEIN CONTAINING PHOSPHORYLATED GLUCOSE RING AND USE THEREOF
#3223HSP60, HSP60 PEPTIDES AND T CELL VACCINES FOR IMMUNOMODULATION
#3224Methods for treatment of cancer by targeting Sirt5
#3225Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3226CAPCNA peptide therapeutics for cancer
#3227Rapid clearance of antigen complexes using novel antibodies
#3228Charged lipoprotein complexes and their uses
#3229HUMAN FERTILITY ENHANCEMENT WITH CORTISOL REDUCTION FOOD
#3230Plasminogen and plasmin variants
#3231Method of Treating Cancer by Administration of Low Levels of Heat Shock Protein 70 (HSP70)
#3232Biomarkers for Painful Intervertebral Discs and Methods of Use Thereof
#3233CTRP6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
#3234DIAGNOSING, MONITORING AND TREATING INFLAMMATION
#3235TREATMENT OF CANCER WITH ALK1 ANTAGONISTS
#3236Methods for treatment of stroke or cerebrovascular accidents using an ETreceptor agonist
#3237Inhibitor of neuronal connectivity linked to schizophrenia susceptibility and cognitive dysfunction
#3238Predicting and treating diabetic complications
#3239SGEF CONTROLS MACULAR, CORPUS CALLOSUM AND HIPPOCAMPAL FUNCTION AND DEVELOPMENT, LIVER HOMEOSTASIS, FUNCTIONS OF THE IMMUNE SYSTEM, FEVER RESPONSE ATHEROSCLEROSIS AND TUMOROGENIC CELL GROWTH
#3240PHAGOCYTIC ACTIVITY AS A MARKER OF SYNUCLEINOPATHIC DISEASE
#3241Treatment of myocardial injury with humanin analogs
#3242Stable formulations for parenteral injection of peptide drugs
#3243Stable formulations for parenteral injection of peptide drugs
#3244Apolipoprotein E polypeptides and their use
#3245Method of inhibiting binding or activity of MIF by administering a MIF antagonist
#3246Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#3247Protection of cells from -RNA-induced degeneration and inhibitors for protecting cells
#3248USE OF A TRUNCATED EIF-5A1 POLYNUCLEOTIDE TO INDUCE APOPTOSIS IN CANCER CELLS
#3249Polymer hydrogels for in vivo applications and methods for using and preparing same
#3250Stable formulations for parenteral injection of peptide drugs
#3251Food supplement having high immunological value, based on a protein matrix
#3252PRESERVATION OF THE NEUROMUSCULAR JUNCTION (NMJ) AFTER TRAUMATIC NERVE INJURY
#3253TNF SUPERFAMILY TRIMERIZATION INHIBITORS
#3254Scaffold-kinase interaction blockades and uses thereof in treating cancer
#3255ERAP1-derived peptide and use thereof
#3256FORMULATION FOR INCREASING BIOAVAILABILITY OF NEURTURIN
#3257Methods and compositions relating to P62 for the treatment and prophylaxis of cancer
#3258Methods for Manipulating Phagocytosis Mediated by CD47
#3259Use of an agent that restores tissue perfusion and oxygenation
#3260Compositions and methods for cancer treatment using targeted carbon nanotubes
#3261Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion
#3262Use of histones for therapeutic purposes
#3263Method for treatment of diabetic vascular leakage-induced disease using C-peptide
#3264REIC-expressing adenovirus vector
#3265METHODS AND COMPOSITIONS FOR ENHANCING THE UPTAKE OF THERAPEUTIC AGENTS BY TARGET CELLS
#3266Selective targeting of the CD40L/Mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis
#3267Manufacturing and purification processes of Complex protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Antitrypsin (A1AT) or a combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#3268USE OF REGULATOR OF CALCINEURIN 1 FOR MANUFACTURING MEDICAMENT FOR TREATMENT OF DISEASES ASSOCIATED WITH INCREASED NF-KB ACTIVITY
#3269Sustained release formulations for delivery of proteins to the eye and methods of preparing same
#3270Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin, and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin/Apo/Human Albumin/A1AT and all new found proteins
#3271Mitochondrial targeting and therapeutic use thereof
#3272Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition
#3273Treatment of extracellular matrix to reduce inflammation
#3274Anti-tumor drug, medicament, composition, and use thereof
#3275Type I interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
#3276MIR-211 EXPRESSION AND RELATED PATHWAYS IN HUMAN MELANOMA
#3277Methods for P2RY5 Mediated Regulation of Hair Growth and Mutants Thereof
#3278Method for prevention or treatment of diabetic angiogenesis impairment using C-peptide
#3279Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
#3280Treatment and prevention of cancer with HMGB1 antagonists
#3281IMMUNITY INDUCING AGENT
#3282Use of peptides for promoting wound healing
#3283APLs for treating arthritis
#3284Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9
#3285Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
#3286Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content
#3287Methods and compositions for modulating myofibroblast activities
#3288Ophthalmic device, and method of use thereof, for increasing ocular boundary lubrication
#3289USE OF LIGHT SENSITIVE GENES
#3290SPARC ANGIOGENIC DOMAIN AND METHODS OF USE
#3291PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS
#3292Method for screening a glutamate release inhibitor in an astrocyte
#3293GENE TRANSFER FOR REGULATING SMOOTH MUSCLE TONE
#3294Compositions and methods for treatment of gynecologic cancers
#3295Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers
#3296Methods for treating castration resistant prostate cancer and metastasis by reducing B-cell number and/or function
#3297Dry powder inhaler and system for drug delivery
#3298METHOD FOR IMPROVING ENDOTHELIAL FUNCTION AND DECREASING CARDIOVASCULAR MORBIDITY USING SHILAJIT
#3299Compositions and Methods for Treating Cutaneous Scarring
#3300Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain